00202-3/asset/7c9ee60c-81a4-493f-89fd-d6f37616dfa3/main.assets/gr3_lrg.jpg)
orforglipron semaglutide comparison Efficacy and safety of once-daily oral compared with oral in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial obesity #diabetes #endocrinology #glp1 #obesitytreatment
Description
The investment will support a Phase IIa clinical study of CSTI-500 in individuals with PWS, expected to begin in 2026
GLP-1 receptors are expressed in mesolimbic reward brain regions, including the nucleus accumbens
Gliatto MF, Rai AK
These trials were a key step in demonstrating the efficacy of these drugs in terms of weight management and metabolic improvements for individuals with type 2 diabetes [8,9]
Booking a consultation does not mean this medication will be prescribed for you
Standard surgical guidelines recommend stopping semaglutide injections at least 48 hours before elective procedures
